A cost-benefit analysis of voluntary routine HIV-antibody testing for hospital patients
- 1 May 1996
- journal article
- Published by Elsevier in Social Science & Medicine
- Vol. 42 (9) , 1259-1272
- https://doi.org/10.1016/0277-9536(95)00221-9
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Evaluation of the Quality of Life Associated with Zidovudine Treatment in Asymptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1994
- Cost effectiveness analysis of early zidovudine treatment of HIV infected patients.BMJ, 1993
- Human immunodeficiency virus counseling, testing, referral, and partner notification services. A cost-benefit analysisArchives of internal medicine (1960), 1993
- Who should be screened for HIV infection? A cost-effectiveness analysisArchives of internal medicine (1960), 1993
- A Second Look at the Cost of Mandatory Human Immunodeficiency Virus and Hepatitis B Virus Testing for Healthcare Workers Performing Invasive ProceduresInfection Control & Hospital Epidemiology, 1992
- Evidence for the effects of HIV antibody counseling and testing on risk behaviorsJAMA, 1991
- Benefits and Costs of HIV testingScience, 1991
- Screening blood donors for human immunodeficiency virus antibody: cost-benefit analysis.American Journal of Public Health, 1988
- Compensating Wage Differentials and the Endogeneity of Job RiskinessThe Review of Economics and Statistics, 1988
- Compensating Wage Differentials and Public Policy: A ReviewILR Review, 1979